105 related articles for article (PubMed ID: 22034781)
1. Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.
Soldić Z; Murgić J; Jazvić M; Radić J; Bolanca A; Stancić V; Kusić Z
Acta Clin Croat; 2011 Mar; 50(1):29-35. PubMed ID: 22034781
[TBL] [Abstract][Full Text] [Related]
2. Low dose palliative radiotherapy for splenomegaly in hematologic disorders.
Lavrenkov K; Krepel-Volsky S; Levi I; Ariad S
Leuk Lymphoma; 2012 Mar; 53(3):430-4. PubMed ID: 21848363
[TBL] [Abstract][Full Text] [Related]
3. Short-time splenic irradiation for splenomegaly.
Schratter-Sehn AU; Cerveny M; Simmel H; Schlögl E; Schratter A
Onkologie; 2003 Feb; 26(1):21-4. PubMed ID: 12624513
[TBL] [Abstract][Full Text] [Related]
4. Low-dose palliative splenic irradiation in haematolymphoid malignancy.
Shrimali RK; Correa PD; O'Rourke N
J Med Imaging Radiat Oncol; 2008 Jun; 52(3):297-302. PubMed ID: 18477126
[TBL] [Abstract][Full Text] [Related]
5. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
[TBL] [Abstract][Full Text] [Related]
6. Splenic irradiation for splenomegaly: A systematic review.
Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE
Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304
[TBL] [Abstract][Full Text] [Related]
7. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V
J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067
[TBL] [Abstract][Full Text] [Related]
8. [Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases].
Sciascia R; Mazza P; Tondi L
Radiol Med; 1988; 76(1-2):87-90. PubMed ID: 3399713
[TBL] [Abstract][Full Text] [Related]
9. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation.
Liauw SL; Yeh AM; Morris CG; Olivier KR; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1440-5. PubMed ID: 16997504
[TBL] [Abstract][Full Text] [Related]
10. Palliative irradiation of the spleen.
McFarland JT; Kuzma C; Millard FE; Johnstone PA
Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892
[TBL] [Abstract][Full Text] [Related]
11. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
Wagner H; McKeough PG; Desforges J; Madoc-Jones H
Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for splenomegaly.
Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
[TBL] [Abstract][Full Text] [Related]
13. A study of splenic irradiation in chronic lymphocytic leukemia.
Guiney MJ; Liew KH; Quong GG; Cooper IA
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):225-9. PubMed ID: 2912945
[TBL] [Abstract][Full Text] [Related]
14. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders.
Paulino AC; Reddy SP
Am J Hosp Palliat Care; 1996; 13(6):32-5. PubMed ID: 8945101
[TBL] [Abstract][Full Text] [Related]
15. Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma.
Ng M; Wirth A; Ryan G; MacManus M; Davis S
Australas Radiol; 2006 Jun; 50(3):222-7. PubMed ID: 16732818
[TBL] [Abstract][Full Text] [Related]
16. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
[TBL] [Abstract][Full Text] [Related]
17. Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis.
Riesterer O; Gmür J; Lütolf U
Onkologie; 2008 Jun; 31(6):325-7. PubMed ID: 18547974
[TBL] [Abstract][Full Text] [Related]
18. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA
Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
[TBL] [Abstract][Full Text] [Related]
19. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
20. [Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis].
Slanina J; Vondraczek A; Wannenmacher M
Dtsch Med Wochenschr; 1986 Jul; 111(30):1144-50. PubMed ID: 2426078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
